Clinical Trial Update: Comparison of Apixaban Versus Enoxaparin [NA]

View source ↗

Summary

A clinical trial is currently enrolling by invitation to compare apixaban versus enoxaparin in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Apixaban (apixaban)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Bladder Cancer | NA | Status: ENROLLING_BY_INVITATION